Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
The STEMI Door-to-Unload (DTU) Clinical Trial Programme
Author(s): Navin K Kapur Added: 2 years ago

Intervention
TCT 23: Late-Breaking Clinical Trials Revealed
Added: 2 years ago Source:  Radcliffe Cardiology
Find out what's hot at TCT in this preview from Prof Nicolas Van Mieghem and Dr Joost Daemen The Cardiovascular Research Foundation (CRF) has unveiled the late-breaking clinical trials scheduled for presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting taking place from October 23 to 26 in San Francisco. TCT is renowned for showcasing groundbreaking research in… View more

Intervention
TCT 25: 5 Trials That Will Change My Practice with Dr Mirvat Alasnag
Author(s): Mirvat Alasnag Added: 4 months ago
TCT 2025 - In this insightful highlights video from TCT 2025, Dr Mirvat Alasnag (King Fahad Armed Forces Hospital, SA) provides expert commentary on the most impactful late-breaking clinical trials presented at this year's conference.The commentary distills the most important late-breaking trials in structural cardiology, coronary interventions, and artificial intelligence presented at TCT 2025… View more

Digital Health

Guidelines & Statements
PCI Strategies for Calcified Lesions: Systematic Review
Author(s): Andreas Torp Kristensen , Pascal Faltermeier , Caroline Barkholt Kamp , et al Added: 3 months ago

Imaging & Diagnostics

Intervention
TR Aetiology & Clinical Outcomes with Prof Denisa Muraru
Author(s): Denisa Muraru Added: 2 months ago
Discover why tricuspid regurgitation aetiology matters for patient outcomes and intervention strategies with Prof Denisa MuraruThis presentation, part of a comprehensive series on complex cases in interventional cardiology, explores how understanding TR mechanisms directly impacts diagnosis, treatment selection, and clinical prognosis.Prof Muraru addresses the critical heterogeneity in TR… View more

Intervention
TCT 2025 Unveils its Late-Breaking Trials and Science Sessions
Added: 5 months ago Source:  TCT Conference 2025 Programme Guide
Late-breaking clinical trials and science sessions have been announced for Transcatheter Cardiovascular Therapeutics 2025 conference.The conference is set to take place from 25th to 28th October 2025 at the Moscone Center in San Francisco, CA.Access the full programme here.Late-Breaking Clinical Trials: Session I, in Collaboration with The LancetSunday 26th October, 11:00am – 12:28pm (PDT)One… View more

Intervention

Anticoagulation
Shortened Dual Antiplatelet Therapy
Author(s): Kevin S Tang , Shoujit Banerjee , George Tang , et al Added: 2 years ago

Anticoagulation

Intervention
DAPT Duration Post-PCI: HOST-BR Trial Results
Added: 4 months ago Source:  Radcliffe Cardiology
The optimal duration of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) requires a careful balance between reducing ischaemic events and minimising bleeding risk. The HOST-BR trial was designed to evaluate the ideal DAPT duration in patients stratified by their bleeding risk.¹This open-label, multicentre, randomised clinical trial enrolled 4,897 patients who… View more

Anticoagulation

Intervention
AHA 25: Lp(a) and ASCVD: Translating Causal Evidence into Clinical Practice
Author(s): Michelle O'Donoghue Added: 4 months ago
AHA Scientific Sessions 2025 - Dr Michelle O'Donoghue (Brigham and Women's Hospital, US) joins us to discuss the evolving understanding of the causal relationship between elevated lipoprotein(a) and atherosclerotic cardiovascular disease, and what this means for risk stratification and management strategies in clinical practice.Dr O'Donoghue begins by highlighting the importance for clinicians to… View more

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions